Fortis’s Agilus challenge deepens
Forced to buy out investors of its struggling diagnostics arm, Fortis now has the additional burden of reviving Agilus even as it’s trying to get the core healthcare business back on track.
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
$99 for one year
Not ready to subscribe? Sign up for a free account
We value our free readers. Read 100+ stories every year.
More in Business
You may also like
Several issues are muddying the waters for Kent’s IPO
The popular appliance maker’s DRHP throws up multiple red flags, including large-scale slippages in business performance, that detract from its appeal. Should it then even go public?
Peak XV Partners should win the record outcome test with Pine Labs
Finally, this question will be answered. Who has returned the most amount of capital on any venture investment in India in the last two decades?
Can Amazon pass the diagnostics test?
The e-commerce giant’s entry into the home diagnostics market may have spooked competitors, but it will have to bring its A-game to ace this.
